Monte Rosa Therapeutics Inc (GLUE)
SG&A Expenses
$39.89M
TTM · Period ending: · USD
GLUE SG&A Expenses
Latest reported$39.89Mperiod ending
Latest reported$39.89Mperiod ending
GLUE TTM SG&A Expenses ($4.01M → $39.89M)
TTM SG&A Expenses
High-resolution chart · PNG
GLUE sg&a expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 39,891,000 | |
| 37,852,000 | |
| 36,380,000 | |
| 34,640,000 | |
| 33,702,000 | |
| 34,889,000 | |
| 35,171,000 | |
| 34,122,000 | |
| 34,656,000 | |
| 33,519,000 | |
| 32,038,000 | |
| 31,931,000 | |
| 30,290,000 | |
| 28,440,000 | |
| 27,323,000 | |
| 24,959,000 | |
| 22,692,000 | |
| 19,883,000 | |
| 15,727,000 | |
| 12,543,000 | |
| 8,704,000 | |
| 5,759,000 | |
| 4,006,000 |